cinemark holdings inc. - CNK
CNK
Close Chg Chg %
25.77 -0.92 -3.57%
Closed Market
24.85
-0.92 (3.57%)
Volume: 2.38M
Last Updated:
Mar 28, 2025, 3:59 PM EDT
Company Overview: cinemark holdings inc. - CNK
CNK Key Data
Open $25.49 | Day Range 24.75 - 25.49 |
52 Week Range 16.32 - 36.27 | Market Cap $3.15B |
Shares Outstanding 122.30M | Public Float 109.68M |
Beta 2.43 | Rev. Per Employee N/A |
P/E Ratio 12.66 | EPS $2.54 |
Yield 0.00% | Dividend $0.08 |
EX-DIVIDEND DATE Mar 5, 2025 | SHORT INTEREST N/A |
AVERAGE VOLUME 4.66M |
CNK Performance
1 Week | -1.19% | ||
1 Month | 0.51% | ||
3 Months | -16.83% | ||
1 Year | 43.24% | ||
5 Years | 109.27% |
CNK Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
11
Full Ratings ➔
About cinemark holdings inc. - CNK
Cinemark Holdings, Inc. is a holding company, which engages in the provision of motion picture exhibitions through its subsidiaries. It operates through the U.S. Markets and International Markets segments. The company was founded by Lee Roy Mitchell in 1984 and is headquartered in Plano, TX.
CNK At a Glance
Cinemark Holdings, Inc.
3900 Dallas Parkway
Plano, Texas 75093-7865
Phone | 1-972-665-1000 | Revenue | 3.05B | |
Industry | Movies/Entertainment | Net Income | 304.20M | |
Sector | Consumer Services | Employees | 29,200 | |
Fiscal Year-end | 12 / 2025 | |||
View SEC Filings |
CNK Valuation
P/E Current | 12.439 |
P/E Ratio (with extraordinary items) | N/A |
P/E Ratio (without extraordinary items) | 15.053 |
Price to Sales Ratio | 1.574 |
Price to Book Ratio | 6.375 |
Price to Cash Flow Ratio | 10.298 |
Enterprise Value to EBITDA | 12.871 |
Enterprise Value to Sales | 2.363 |
Total Debt to Enterprise Value | 0.48 |
CNK Efficiency
Revenue/Employee | 104,434.932 |
Income Per Employee | 10,417.808 |
Receivables Turnover | 18.906 |
Total Asset Turnover | 0.616 |
CNK Liquidity
Current Ratio | 1.013 |
Quick Ratio | 0.989 |
Cash Ratio | 0.825 |
CNK Profitability
Gross Margin | 19.036 |
Operating Margin | 11.884 |
Pretax Margin | 8.29 |
Net Margin | 9.975 |
Return on Assets | 6.143 |
Return on Equity | 67.286 |
Return on Total Capital | 7.51 |
Return on Invested Capital | 8.708 |
CNK Capital Structure
Total Debt to Total Equity | 581.443 |
Total Debt to Total Capital | 85.325 |
Total Debt to Total Assets | 68.208 |
Long-Term Debt to Equity | 465.057 |
Long-Term Debt to Total Capital | 68.246 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Cinemark Holdings Inc. - CNK
Collapse All in section
All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
---|---|---|---|---|---|
Sales/Revenue
| 1.51B | 2.45B | 3.07B | 3.05B | |
Sales Growth
| +120.08% | +62.51% | +24.93% | -0.56% | |
Cost of Goods Sold (COGS) incl D&A
| 1.57B | 2.20B | 2.50B | 2.47B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 261.91M | 227.40M | 209.50M | 197.50M | |
Depreciation
| 259.23M | 224.90M | 207.30M | 195.40M | |
Amortization of Intangibles
| 2.68M | 2.50M | 2.20M | 2.10M | |
COGS Growth
| +36.92% | +39.78% | +13.45% | -1.09% | |
Gross Income
| (63.53M) | 254.60M | 570.60M | 580.50M | |
Gross Income Growth
| +86.29% | +500.77% | +124.12% | +1.74% | |
Gross Profit Margin
| -4.21% | +10.37% | +18.61% | +19.04% |
2021 | 2022 | 2023 | 2024 | 5-year trend | |
---|---|---|---|---|---|
SG&A Expense
| 161.08M | 177.60M | 198.80M | 218.10M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 161.08M | 177.60M | 198.80M | 218.10M | |
SGA Growth
| +26.24% | +10.26% | +11.94% | +9.71% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 26.37M | 173.60M | 14.90M | (2.60M) | |
EBIT after Unusual Expense
| (250.97M) | (96.60M) | 356.90M | 365.00M | |
Non Operating Income/Expense
| (14.73M) | 10.10M | 37.50M | 53.80M | |
Non-Operating Interest Income
| 6.40M | 20.40M | 55.00M | 53.20M | |
Equity in Earnings of Affiliates
| (25.05M) | (9.30M) | 3.60M | 11.90M | |
Interest Expense
| 173.31M | 178.50M | 173.00M | 166.00M | |
Interest Expense Growth
| +12.93% | +2.99% | -3.08% | -4.05% | |
Gross Interest Expense
| 173.31M | 178.50M | 173.00M | 166.00M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (439.02M) | (265.00M) | 221.40M | 252.80M | |
Pretax Income Growth
| +52.66% | +39.64% | +183.55% | +14.18% | |
Pretax Margin
| -29.07% | -10.80% | +7.22% | +8.29% | |
Income Tax
| (16.80M) | 3.00M | 29.90M | (60.10M) | |
Income Tax - Current - Domestic
| 5.03M | 3.10M | 5.10M | 35.50M | |
Income Tax - Current - Foreign
| 794.00K | 9.20M | 14.20M | 15.20M | |
Income Tax - Deferred - Domestic
| (23.04M) | (6.90M) | 16.30M | (74.80M) | |
Income Tax - Deferred - Foreign
| 409.00K | (2.40M) | (5.70M) | (36.00M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| (25.05M) | (9.30M) | 3.60M | 11.90M | |
Other After Tax Income (Expense)
| 6.06M | 3.80M | (3.30M) | (5.50M) | |
Consolidated Net Income
| (416.16M) | (264.20M) | 188.20M | 307.40M | |
Minority Interest Expense
| 568.00K | 3.20M | 3.30M | 3.20M | |
Net Income
| (416.73M) | (267.40M) | 184.90M | 304.20M | |
Net Income Growth
| +31.97% | +35.83% | +169.15% | +64.52% | |
Net Margin Growth
| -27.59% | -10.89% | +6.03% | +9.98% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (416.73M) | (267.40M) | 184.90M | 304.20M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (416.73M) | (267.40M) | 184.90M | 304.20M | |
EPS (Basic)
| -3.5542 | -2.2623 | 1.5525 | 2.5371 | |
EPS (Basic) Growth
| +32.31% | +36.35% | +168.62% | +63.42% | |
Basic Shares Outstanding
| 117.25M | 118.20M | 119.10M | 119.90M | |
EPS (Diluted)
| -3.5542 | -2.2623 | 1.3362 | 2.0581 | |
EPS (Diluted) Growth
| +32.31% | +36.35% | +159.06% | +54.03% | |
Diluted Shares Outstanding
| 117.25M | 118.20M | 152.00M | 154.90M | |
EBITDA
| 37.31M | 304.40M | 581.30M | 559.90M | |
EBITDA Growth
| +111.35% | +715.89% | +90.97% | -3.68% | |
EBITDA Margin
| +2.47% | +12.40% | +18.96% | +18.36% |
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 32.30 | |
Number of Ratings | 11 | Current Quarters Estimate | -0.044 | |
FY Report Date | 03 / 2025 | Current Year's Estimate | 1.666 | |
Last Quarter’s Earnings | 0.33 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 2.06 | Next Fiscal Year Estimate | 2.063 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 9 | 9 | 9 | 9 |
Mean Estimate | -0.04 | 0.62 | 1.67 | 2.06 |
High Estimates | 0.06 | 0.80 | 2.16 | 2.85 |
Low Estimate | -0.26 | 0.48 | 1.29 | 1.63 |
Coefficient of Variance | -213.70 | 18.05 | 15.92 | 21.06 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 7 | 6 | 6 |
OVERWEIGHT | 0 | 0 | 0 |
HOLD | 3 | 4 | 4 |
UNDERWEIGHT | 0 | 0 | 0 |
SELL | 1 | 1 | 1 |
MEAN | Overweight | Overweight | Overweight |
SEC Filings for Cinemark Holdings Inc. - CNK
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Cinemark Holdings Inc. - CNK
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Feb 26, 2025 | Michael D. Cavalier EVP-General Counsel | 324,658 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 8,911,862.10 |
Feb 26, 2025 | Melissa Hayes Thomas EVP, Chief Financial Officer | 252,994 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 26, 2025 | Sean Gamble Chief Executive Officer | 588,624 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 16,157,728.80 |
Feb 26, 2025 | Sean Gamble Chief Executive Officer | 678,731 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 18,631,165.95 |
Feb 26, 2025 | Sean Gamble Chief Executive Officer | 690,154 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 26, 2025 | Melissa Hayes Thomas EVP, Chief Financial Officer | 249,881 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 6,859,233.45 |
Feb 26, 2025 | Caren Bedard SVP-Global Controller | 32,448 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 890,697.60 |
Feb 26, 2025 | Melissa Hayes Thomas EVP, Chief Financial Officer | 225,368 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 6,186,351.60 |
Feb 26, 2025 | Caren Bedard SVP-Global Controller | 29,658 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 814,112.10 |
Feb 26, 2025 | Michael D. Cavalier EVP-General Counsel | 53,137 | Bona fide gift | 0.00 |
Feb 26, 2025 | Michael D. Cavalier EVP-General Counsel | 299,718 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 8,227,259.10 |
Feb 26, 2025 | Wanda Marie Gierhart Chief Marketing & Content Ofc | 179,252 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 26, 2025 | Michael D. Cavalier EVP-General Counsel | 327,825 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 26, 2025 | Caren Bedard SVP-Global Controller | 32,979 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 26, 2025 | Valmir Fernandes Pr - Cinemark International | 155,612 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 4,271,549.40 |
Feb 26, 2025 | Valmir Fernandes Pr - Cinemark International | 176,258 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 4,838,282.10 |
Feb 26, 2025 | Valmir Fernandes Pr - Cinemark International | 178,880 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 26, 2025 | Wanda Marie Gierhart Chief Marketing & Content Ofc | 147,414 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $27 per share | 3,980,178.00 |
Feb 26, 2025 | Wanda Marie Gierhart Chief Marketing & Content Ofc | 156,533 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 4,296,830.85 |
Feb 26, 2025 | Wanda Marie Gierhart Chief Marketing & Content Ofc | 176,692 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $27.45 per share | 4,850,195.40 |
Cinemark Holdings Inc. in the News
Movie theater customers are spending more money after reopenings
The summer blockbuster is back after movie theaters across the country have reopened from their pandemic shutdowns – and so are the ever-rising costs of seeing new flicks in the theater.
AMC, Regal and Cinemark will no longer require masks for vaccinated guests
The movie chains' guidelines are in line with the CDC's recommendations -- masks are optional for vaccinated individuals, while they are “strongly encouraged” for everyone else.